Hospitalizations in Pregnancy, Delivery Stable for HIV-Infected

Share this content:
Hospitalizations in Pregnancy, Delivery Stable for HIV-Infected
Hospitalizations in Pregnancy, Delivery Stable for HIV-Infected

MONDAY, Oct. 10, 2016 (HealthDay News) -- From 2004 to 2011 there was no increase in the number of hospitalizations during pregnancy and delivery for HIV-infected women, according to a study published in the October issue of the American Journal of Obstetrics & Gynecology.

Alexander C. Ewing, M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues compared rates of hospitalizations and associated outcomes for HIV-infected and uninfected pregnant women from 2004 through 2011. Hospital discharge data were obtained for women aged 15 to 49 years from the 2004, 2007, and 2011 Nationwide Inpatient Sample.

The researchers found that there were 4,751 estimated pregnancy hospitalizations and 3,855 delivery hospitalizations for HIV-infected pregnant women in 2011, with no increases since 2004. Pregnancy hospitalizations of HIV-infected women were more likely to be longer, be in the South and Northeast, be covered by public insurance, and incur higher charges compared with those of HIV-uninfected women (all P < 0.005). Higher odds of many adverse outcomes were seen for hospitalizations among pregnant women with HIV. In 2011, the odds of gestational diabetes, preeclampsia/hypertensive disorders of pregnancy, viral/mycotic/parasitic infections, and bacterial infections were increased compared with 2004 in hospitalizations of HIV-infected pregnant women (adjusted odds ratios, 1.81, 1.58, 1.90, and 2.54, respectively). Among hospitalizations of HIV-uninfected women there was no increase in bacterial infections.

"Pregnancy hospitalizations of HIV-infected women remain more medically complex than those of HIV-uninfected women," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Price Transparency Intervention Doesn't Cut Lab Test Orders

Price Transparency Intervention Doesn't Cut Lab Test Orders

No significant changes in overall test-ordering behavior or associated fees in adjusted analyses

More Risks on School Playgrounds Linked to Happier Children

More Risks on School Playgrounds Linked to Happier ...

Greater opportunities for risk, challenge associated with fewer reports of bullying to adults

Black Men Have Higher Rate of Preclinical Prostate Cancer

Black Men Have Higher Rate of Preclinical Prostate ...

Also increased risk of progression to metastatic disease compared with the general population

is free, fast, and customized just for you!

Already a member?

Sign In Now »